Work

India's 2024 Ban on Fixed-Dose Combinations: Implications for Safety, Efficacy, and Regulatory Policy

Year: 2025

Type: article

Source: Applied Drug Research Clinical Trials and Regulatory Affairs

DOI: 10.2174/0126673371389705250825195039

Authors: Prachi Pandey, Kumari Komal, Debayan Sil, Dinesh Kumar, Saurabh Kumar, Rohit Sharma, Manish Kumar

Institution: Indo Soviet Friendship College of Pharmacy

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414072768

FWCI:

Cites:

Cited by:

Related to: 10